In addition to launching a corporate venture capital fund, Daikin has inked a deal with University of Tokyo to drive the formation of spinouts.

Chinese Academy of Sciences' Cash Capital put up a share of the funds for oncological drug developer OnQuality Pharmaceuticals' first funding round.

Stanford-StartX Fund portfolio company Sensely collected funding from a consortium led by insurance firm Aflac to haul its lifetime total to $26.5m.

Genomics bioinformatics platform developer PierianDx, a Washington University in St Louis spinout, has raised fresh capital to advance its business strategy.

University of Pennsylvania returned for a series B round that boosted its immunotherapy spinout's overall funding to $231m.

University of Pennsylvania spinout Cabaletta has gone public after raising $74.8m in an initial public offering on the Nasdaq Global Select Market.

Prime Medicine will work alongside Harvard University-founded Beam Therapeutics to commercialise Broad Institute faculty vice-chair David Liu's single-base DNA editing inventions.

Sense Biodetection has raised $15.8m in a series A round co-led by Cambridge Innovation Capital and Earlybird to produce a diagnostic test for infectious diseases.

KCK has wholly acquired University of Edinburgh spinout Dukosi, which will continue to operate from its Scotland base ahead of a global expansion.

Having already collected $68m in a series A round backed by Stanford University earlier this year, Sandbox VR has added $11m to its coffers thanks to a long list of celebrities.